<DOC>
	<DOCNO>NCT00169858</DOCNO>
	<brief_summary>Hepatitis B immunization offer grade 4 student ( age 9-10 ) province Quebec , use Engerix-B dose 10 mkg . The peak incidence hepatitis B occur age 15 35 ; proportion vaccinate child still protect age currently unknown . This study design determine : - persistence immunity age 25 - persistence immunological memory demonstrate anamnestic response follow booster dose - effect booster dose immunogenicity either 5 , 10 15 year primary vaccination course ( age ( 15 , 20 25 ) .</brief_summary>
	<brief_title>Long Term Immunogenicity Study Engerix-B Vaccine 10 Year Old Children Effect Booster Injections</brief_title>
	<detailed_description>Three dose Engerix-B vaccine ( 10 mkg ) administer accord 0 , 1 , 6 month schedule 1126 9-10 year-old child . The primary objective study evaluate persistence antibody Engerix-B subject age 25 compare level obtain give booster injection age 15 20 receiving booster injection . Secondary objective - To determine antibody level obtain follow primary vaccination proportion child seroconvert - To determine antibody level one third subject age 15 , 5 year primary vaccination ( Group A ) - To determine effect antibody level booster injection age 15 year give one third subject ( Group A ) - To determine antibody level subject group A B age 20 , 5 year booster ( Group A ) , 10 year primary vaccination ( Group B ) - To determine effect antibody level booster injection age 20 year give one third subject ( Group B ) - To determine effect antibody level booster injection age 25 year give one third subject ( Group C ) - To determine antibody level subject Group A Group B one year 5 10 year booster - To evaluate safety</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Previously complete 1995 1996 Hepatitis B vaccination program vaccination ( Primary study ) best his/her knowledge already enrol follow long term study Must HBc negative Required standard interval last dose primary immunization booster vaccination Written inform consent obtain subject Free obvious health problem establish medical history clinical examination enter study Previously complete routine childhood vaccination best his/her knowledge If subject female , potential pregnancy exists , must ask prior immunization study nurse . According protocol d'immunisation du Qu√©bec , EngerixB contraindicate pregnancy . However , participant think could pregnant ( sexually active oral contraception intra uterine device ) , pregnancy test carry . In case pregnancy , booster vaccination perform delivery . Not applicable</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Engerix-B</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Long-term immunity</keyword>
	<keyword>Booster dose</keyword>
	<keyword>Safety</keyword>
</DOC>